Results 211 to 220 of about 920,092 (279)
Some of the next articles are maybe not open access.
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
ChemInform, 2004AbstractFor Abstract see ChemInform Abstract in Full Text.
Mario, Delgado +2 more
openaire +2 more sources
Vasoactive intestinal peptide producing neuroblastoma
Journal of Pediatric Surgery, 1982The Verner-Morrison syndrome has been described in 19 previous patients with ganglioneuroma and ganglioneuroblastoma but never neuroblastoma. Its occurrence following treatment of a neuroblastoma with chemotherapy with maturation of the tumor has only been reported on one previous occasion.
D R, Cooney +5 more
openaire +2 more sources
Stabilization of Vasoactive Intestinal Peptide by Lipids
The Journal of Pharmacology and Experimental Therapeutics, 1998An anionic phospholipid, phosphatidylglycerol (PG), induced vasoactive intestinal peptide (VIP) to adopt a helical conformation, determined by circular dichroism studies. PG inhibited the trypsin-catalyzed, antibody-catalyzed and uncatalyzed cleavage of VIP, measured by radiometric and HPLC methods.
G, Gololobov +5 more
openaire +2 more sources
Vasoactive Intestinal Peptide and Nerve Regeneration
Journal of Hand Surgery, 1991The role of vasoactive intestinal peptide (V.I.P.) in nerve regeneration was investigated by assessing the changes in immunoreactive V.I.P. levels in rat sciatic nerves following injury and repair. 60 rats were divided into three surgical groups and one control group: In group I (primary repair), sciatic nerves were divided and immediately repaired; in
G M, Rayan +3 more
openaire +2 more sources
Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
Journal of Pharmacology and Experimental Therapeutics, 1986Binding of [125I]vasoactive intestinal peptide (VIP) to human and guinea pig lung sections was characterized and VIP receptors localized by light-microscopic autoradiography. Inhibition of [125I] VIP binding by unlabeled VIP, peptide histidine isoleucine,
J. Carstairs, P. J. Barnes
semanticscholar +1 more source
Vasoactive intestinal peptide in cerebrospinal fluid
Peptides, 1984Immunoreactive vasoactive intestinal peptide (VIP) was measured in lumbar and ventricular cerebrospinal fluid (CSF) from patients with various neurological disorders and in 2 hour aliquots of cisternal fluid removed continuously from rhesus monkeys. Although most of the VIP in concentrated pools of human ventricular fluid and of monkey cisternal fluid ...
N S, Sharpless +8 more
openaire +2 more sources
1994
A 28 amino acid single chain polypeptide, (M.Wt. 3381 Da) showing several similarities in amino acid sequence to other gastrointestinal hormones.
openaire +1 more source
A 28 amino acid single chain polypeptide, (M.Wt. 3381 Da) showing several similarities in amino acid sequence to other gastrointestinal hormones.
openaire +1 more source
Vasoactive intestinal peptide: A chronoimmunomodulator?
Biochemical Medicine and Metabolic Biology, 1991CUGINI, Pietro +7 more
openaire +3 more sources
Transmitter Role of Vasoactive Intestinal Peptide
Pharmacology & Toxicology, 1993Abstract: Vasoactive intestinal polypeptide (VIP) is a 28 amino acid with a wide‐spread neuronal localization. VIP fulfils many of the classical criteria for neurotransmission. In the cerebral cortex bipolar VIP neurones are involved in the coupling between energy metabolism, blood flow and neuronal activity. Furthermore, VIP in the brain plays a role
openaire +2 more sources
The effects of vasoactive intestinal peptide in neurodegenerative disorders
Neurological Research, 2017G. Deng, Lan Jin
semanticscholar +1 more source

